Keywords: cizzle, secures, vc, funding, cancer, uk-based, biotechnology

Cizzle secures VC funding for cancer R&D

Article | 24 July 2006

Print This

UK-based Cizzle Biotechnology, a spin-out company from the University of York, says it has secured funding from the White Rose ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in